Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e39938
Publisher
Public Library of Science (PLoS)
Online
2012-06-29
DOI
10.1371/journal.pone.0039938
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
- (2012) Andrew S. Bomback et al. BLOOD PURIFICATION
- ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial
- (2011) S.M. Titan et al. CLINICAL NEPHROLOGY
- Glucose handling by the kidney
- (2011) Amanda Mather et al. KIDNEY INTERNATIONAL
- C-Peptide Increases Na,K-ATPase Expression via PKC- and MAP Kinase-Dependent Activation of Transcription Factor ZEB in Human Renal Tubular Cells
- (2011) Dana Galuska et al. PLoS One
- Standards of Medical Care in Diabetes--2011
- (2010) DIABETES CARE
- The cardiorenal syndrome in diabetes mellitus
- (2010) Hussein H. Karnib et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet
- (2010) Tsutomu Wada et al. ENDOCRINOLOGY
- Insulin induced translocation of Na+/K+-ATPase is decreased in the heart of streptozotocin diabetic rats
- (2009) Klara Rosta et al. ACTA PHARMACOLOGICA SINICA
- Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats
- (2009) Paola Failli et al. Cardiovascular Diabetology
- Managing diabetic dyslipidemia: Beyond statin therapy
- (2009) Hemanth Neeli et al. Current Diabetes Reports
- Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
- (2009) Bhoomika R Goyal et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Evidence of O-linked N-acetylglucosamine in diabetic nephropathy
- (2009) Péter Degrell et al. LIFE SCIENCES
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes and cardiovascular autonomic dysfunction: Application of animal models
- (2008) Katia De Angelis et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines
- (2008) Christine Guo et al. CIRCULATION
- Spironolactone exhibits direct renoprotective effects and inhibits renal renin–angiotensin–aldosterone system in diabetic rats
- (2008) Masateru Taira et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome
- (2008) Hirofumi Ueno et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney - another reason for diabetic nephropathy?
- (2008) Andrea Fekete et al. JOURNAL OF PHYSIOLOGY-LONDON
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation